Published in J Pharmacol Exp Ther on February 01, 1994
Role of formulation vehicles in taxane pharmacology. Invest New Drugs (2001) 1.58
Peripheral neuropathy induced by paclitaxel: recent insights and future perspectives. Curr Neuropharmacol (2006) 1.53
Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids. J Drug Target (2005) 1.12
Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval. Onco Targets Ther (2011) 1.04
Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer. Cancer Chemother Pharmacol (2015) 0.94
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials. Br J Pharmacol (2014) 0.90
Effect of cyclosporin A and its vehicle on cardiac and skeletal muscle mitochondria: relationship to efficacy of the respiratory chain. Br J Pharmacol (2001) 0.87
Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study. Br J Cancer (2001) 0.86
Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer. Onco Targets Ther (2009) 0.79
Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor ® EL. Clin Drug Investig (2013) 0.75
Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes. Eur J Cancer (2016) 0.75
Liquid chromatography/tandem mass spectrometry method for quantitation of cremophor el and its applications. Int J Anal Chem (2013) 0.75
Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med (1987) 1.98
The mitotic checkpoint protein hBUB3 and the mRNA export factor hRAE1 interact with GLE2p-binding sequence (GLEBS)-containing proteins. J Biol Chem (2001) 1.84
The syndrome of acute sensory neuropathy: clinical features and electrophysiologic and pathologic changes. Neurology (1990) 1.81
Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc (2001) 1.14
Fatal hepatotoxicity associated with troglitazone. Ann Intern Med (1998) 1.07
Cyclosporin A-induced reversible cortical blindness. J Clin Neuroophthalmol (1988) 0.98
Identification and characterization of a suppressor element in the 5'-flanking region of the mouse androgen receptor gene. Nucleic Acids Res (1994) 0.94
Hepatitis E in the United States: a case of "hog fever"? Mayo Clin Proc (1997) 0.93
Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. Mayo Clin Proc (2001) 0.93
Epileptiform electroencephalographic abnormalities in liver transplant recipients. Ann Neurol (1991) 0.92
The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome. J Hepatol (2001) 0.91
World-Wide Web-based graphical user interfaces for laboratory data. Methods Inf Med (2002) 0.89
Unusual aspects of acute Q fever-associated hepatitis. Mayo Clin Proc (1994) 0.87
Rat hepatocytes transport water mainly via a non-channel-mediated pathway. J Biol Chem (1996) 0.85
Intracerebral hemorrhage in liver transplant recipients. Mayo Clin Proc (1995) 0.84
Kinetic and molecular identification of sodium-dependent glucose transporter in normal rat cholangiocytes. Am J Physiol (1997) 0.83
Pyridoxine neuropathy in rats: specific degeneration of sensory axons. Neurology (1985) 0.83
Hepatic lymphangiomatosis mimicking polycystic liver disease. Mayo Clin Proc (1998) 0.83
Hepatocellular carcinoma cells resist necrosis during anoxia by preventing phospholipase-mediated calpain activation. J Cell Physiol (1996) 0.81
Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience. Am J Gastroenterol (2001) 0.81
Cyclosporine-related leukoencephalopathy and PML in a liver transplant recipient. Transplantation (1995) 0.81
Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen? Hepatology (2000) 0.79
Characteristics of neurite outgrowth from rat spinal ganglia: effects of serum and segmental level. J Neuropathol Exp Neurol (1986) 0.79
Biological activity of a new neuronal growth factor from injured peripheral nerve. Brain Res Dev Brain Res (1989) 0.78
Sexual intercourse: you, me, and the microbe makes three. JAMA (1987) 0.78
Angiotropic large cell lymphoma (intravascular lymphomatosis) occurring after follicular small cleaved cell lymphoma. Mayo Clin Proc (1996) 0.77
Dysarthria and apraxia of speech associated with FK-506 (tacrolimus). Mayo Clin Proc (1996) 0.77
Characterization of a TPA-response element in the 5'-flanking region of the androgen receptor gene. J Androl (1998) 0.76
Ultrastructural changes produced in dorsal root ganglia in vitro by exposure to ethylene oxide from hemodialyzers. J Neuropathol Exp Neurol (1991) 0.76
Cholangiocyte-specific rat liver proteins identified by establishment of a two-dimensional gel protein database. Electrophoresis (1998) 0.76
Quantitative importance of biliary excretion to the turnover of hepatic lysosomal enzymes. Hepatology (1995) 0.75
Near real-time retroflexion detection in colonoscopy. IEEE J Biomed Health Inform (2012) 0.75
Five interval colorectal cancers. Endoscopy (2011) 0.75
[Chronic poisoning due to salicylic acid compounds: frequently not diagnosed or treated wrong]. Ned Tijdschr Geneeskd (1989) 0.75
Eosinophil-mediated bile duct stricture. A case studied by immunohistochemistry. Arch Pathol Lab Med (1992) 0.75
Adrenal medullary transplantation into the brain for treatment of Parkinson's disease: clinical outcome and neurochemical studies. Mayo Clin Proc (1990) 0.75
Residual ethylene oxide in hollow fiber hemodialysis units is neurotoxic in vitro. Ann Neurol (1989) 0.75